EU Strategic Acquirer Buying an Indian Deeptech Company
An EU strategic acquirer buying an Indian deeptech company should not treat the deal as a standard technology share purchase. The core question is whether the acquirer can legally buy control, verify ownership of the technical assets and integrate the business without discovering regulatory, IP or customer-contract blockers after signing.
Deeptech targets often carry value in patents, prototypes, specialist know-how, research collaborations, manufacturing pathways and founder-led engineering teams. That makes legal diligence more than a checklist exercise. The buyer needs a clean view of foreign-investment route, corporate authority, merger-control triggers, IP title and operational contracts before valuation is locked.
Why This Matters
The first issue is whether the EU buyer's investment route is open, capped or conditional. RBI's Master Direction on Foreign Investment in India states that investment by a person resident outside India is subject to entry routes, sectoral caps, investment limits and attendant conditions. For a deeptech target, that review should be tied to the exact activity: software, hardware, defence-adjacent technology, electronics, advanced materials, AI-enabled industrial systems or regulated scientific equipment.
DPIIT's 2026 FDI policy amendment on land-border investment is also a reminder that beneficial ownership and indirect investor links can matter even when the named acquirer is incorporated outside India. An EU corporate buyer should confirm its ownership chain, group structure and acquisition vehicle early, especially where a consortium, fund affiliate or holding company is involved.
Corporate approval is the next layer. The Companies Act, 2013 drives board authority, shareholder approvals, securities transfers, related-party checks, filings and basic company-law validity. A clean share purchase agreement cannot cure a defective cap table, missing board approval or unresolved investor consent.
What Counsel Should Review
Start with the target's constitutional documents, cap table, past investment agreements, ESOP records, board minutes, shareholder consents and securities-transfer history. The acquirer should know who can sign, whose consent is needed, whether any drag, tag, veto, ROFR or liquidation preference affects the transaction and whether any prior round created transfer restrictions.
Then test foreign-investment and sector status. Many Indian deeptech companies describe themselves broadly as software or engineering businesses, but their revenue may sit in regulated manufacturing, defence supply, space-related services, medical devices, energy infrastructure or telecom-adjacent systems. Counsel should map the actual product and customer base against the FDI route, pricing norms, reporting obligations and any required government or regulator approval.
Merger control should be screened early. The Competition Commission of India's combination notice guidance explains that section 5 thresholds under the Competition Act, 2002 can trigger a filing requirement for acquisitions, mergers or amalgamations. Strategic acquirers should also test deal-value and India nexus issues where the target has meaningful Indian operations, revenue, users, assets or pipeline contracts.
IP diligence should not stop at schedules of applications or registrations. Review founder and employee invention assignments, contractor development agreements, university or incubator licences, joint-development terms, government-funded research conditions and any patent or know-how encumbrances. The Patents Act, 1970 is relevant where the acquisition thesis depends on patent ownership, assignment, prosecution posture or freedom to operate.
Customer and supplier contracts need the same attention. Deeptech companies may depend on pilot agreements, research collaborations, component suppliers, manufacturing partners, cloud infrastructure, exclusivity terms, export commitments or milestone-based grants. Change-of-control, assignment, termination, audit, confidentiality and IP-use clauses can affect whether the EU buyer receives the business it thinks it is buying.
Typical Timeline and Cost Range
A focused legal diligence review for one Indian deeptech target can often be completed in 2-4 weeks once the data room is complete. A transaction involving regulated technology, complex IP chains, foreign-investment approvals, CCI analysis or multiple group entities may take longer and should be sequenced before signing milestones are fixed.
Cost planning should be staged. First confirm transaction route, approval triggers and ownership gaps. Then run deeper specialist review on patents, contracts, employment, incentives and regulated activity only where the commercial thesis depends on those points.
Common Mistakes
- Assuming an EU buyer automatically falls under the automatic route. The actual analysis depends on activity, sector, ownership chain, instrument, pricing and any approval-linked conditions.
- Treating patents as proof of technology ownership. The buyer must connect filings to inventors, assignments, product lines, prosecution status and any university, contractor or funding restrictions.
- Leaving CCI and customer-consent checks until signing. Merger-control timing and contract consent rights can change deal timetable, closing certainty and risk allocation.
How KAS & Co. Can Help
KAS & Co. helps strategic acquirers and deal teams diligence Indian technology targets, test foreign-investment and CCI issues, review IP ownership and negotiate transaction documents. For a focused review before signing an India-linked deeptech acquisition, contact KAS & Co..
FAQs
1. Can an EU company acquire an Indian deeptech company under the automatic route?
Often yes, but not always. The route depends on the target's sector, activities, instrument, ownership chain, pricing and whether any approval-linked conditions apply to the business.
2. What should the buyer check first in an Indian deeptech acquisition?
Start with FDI route, cap table authority, investor consents, CCI screening, IP ownership, key customer contracts and any regulated activity tied to the target's technology.
3. Does a patent portfolio make the target acquisition-ready?
No. The buyer should test whether the patents are owned by the target, linked to the products being acquired, free from encumbrances and supported by complete inventor and assignment records.
4. When should CCI analysis begin?
CCI screening should begin before signing, not at closing. If notification is required, the transaction timetable, closing conditions and long-stop date need to account for that process.
Sources
Topics
Need legal advice on this topic?
KAS & Co. provides strategic legal counsel across technology law, data privacy, IP and commercial advisory.
Schedule a Consultation